Ajax-Loading

Novartis AG - Ebit Interest Coverage

Novartis AG's Fiscal Year is From January To December.

The item "Ebit-Interest-Coverage" stands at 15.63 as of 09/30/2025, the highest value since 12/31/2022.

As of the end of Novartis AG's third quarter, the item "Ebit Interest Coverage" stands at 15.63. This represents an increase of 4.13 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 11.69 percent compared to the value the year prior.
The 1 year change in percent is 11.69.
The 3 year change in percent is -47.12.

The Serie's long term average value is 16.49. It's latest available value, on 09/30/2025, is 5.21 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2023, to it's latest available value, on 09/30/2025, is +53.85%.
The Serie's change in percent from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -53.65%.

Ebit Interest Coverage for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Ebit Interest Coverage905,699,262,464.00
LogoJohnson & Johnson - Ebit Interest Coverage486,508,953,600.00
LogoAbbVie Inc - Ebit Interest Coverage399,570,305,024.00
LogoRoche Holding AG - Ebit Interest Coverage317,433,206,677.55
LogoAstraZeneca PLC - Ebit Interest Coverage280,205,508,085.11